Influx Healthtech Q4 FY26 Results: PAT Rs 2.1 Cr
- May 21, 2026
- Posted by: Neeraj Pandey
- Category: News
Influx Healthtech Q4 FY26 results were declared on May 20, 2026. The company reported PAT of Rs 2.1 crore for the quarter ended March 31, 2026, up 16.7% YoY compared to Rs 1.8 crore in Q4 FY25. Revenue from operations stood at Rs 28.5 crore, up 17.8% YoY. Results are on a Consolidated basis. Influx Healthtech is a Healthcare Technology company listed on Indian stock exchanges.
Click Here – Get Free Investment Predictions
Influx Healthtech Q4 FY26 Financial Highlights
| Metric | Q4 FY26 (Rs Cr) | Q4 FY25 (Rs Cr) | YoY Change |
|---|---|---|---|
| Revenue | 28.5 | 24.2 | +17.8% |
| Net Profit | 2.1 | 1.8 | +16.7% |
| Basis | Consolidated | ||
Note: Q4 FY26 results declared May 20 2026. Healthcare technology solutions company. Verify from BSE/NSE audited filings before investment decisions.
Influx Healthtech Q4 FY26 Performance Analysis
The Influx Healthtech Q4 FY26 results reflect the company’s performance for the January to March 2026 quarter. The company delivered stable results in line with sector trends. Influx Healthtech operates in the Healthcare Technology sector, supported by India’s GDP growth above 6.5% and domestic demand momentum during FY26.
The 16.7% YoY PAT growth in Influx Healthtech Q4 FY26 reflects near-term profitability headwinds with management focus on cost management.
Screen the best stocks on the Univest Screener.
Key Factors Driving Influx Healthtech Q4 FY26 Results
Revenue Performance Q4 FY26
Influx Healthtech Q4 FY26 revenue of Rs 28.5 crore(up 17.8% YoY) reflects demand conditions in the Healthcare Technology sector during the January to March 2026 period. India’s macro environment with GDP above 6.5% and fiscal year-end demand supported business activity across sectors.
Profitability and Margin Analysis
The Influx Healthtech Q4 FY26 PAT of Rs 2.1 crore up 16.7% YoY. Sustaining and growing profitability will be the primary focus entering FY27.
FY27 Outlook
Following Influx Healthtech Q4 FY26 results, management guidance on FY27 revenue growth, margin improvement, and capital allocation will be key investor watchpoints. The Healthcare Technology sector continues to benefit from India’s long-term growth story, government policy support, and rising domestic consumption trends.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on Influx Healthtech Q4 FY26
What is Influx Healthtech Q4 FY26 net profit?
Ans. Influx Healthtech Q4 FY26 PAT of Rs 2.1 crore, up 16.7% YoY from Rs 1.8 crore in Q4 FY25. Results declared May 20, 2026 on a Consolidated basis.
What is Influx Healthtech Q4 FY26 revenue?
Ans. Influx Healthtech Q4 FY26 revenue was Rs 28.5 crore, up 17.8% YoY. Verify full audited breakdown from BSE/NSE filings.
When were Influx Healthtech Q4 FY26 results declared?
Ans. Influx Healthtech Q4 FY26 results were declared on May 20, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.
Is Influx Healthtech a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk tolerance. This article is educational only. Consult a SEBI-registered financial advisor before investing in Influx Healthtech.
